hydroxyproline has been researched along with atorvastatin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Hu, SJ; Kang, L | 1 |
Awada, M; Bautista, A; Gardner, JL; Hellerstein, MK; Lindwall, G; Turner, SM | 1 |
Biecker, E; Heller, J; Hennenberg, M; Laleman, W; Nevens, F; Sauerbruch, T; Schepke, M; Shelest, N; Trebicka, J | 1 |
Geng, J; Kang, W; Wang, W; Zhang, Y; Zhao, Z; Zhiming, GE | 1 |
Bi, Q; Bolli, R; Dawn, B; Hunt, G; Peng, Y; Sanganalmath, SK; Sato, H; Shirk, G; Tang, XL; Vincent, RJ | 1 |
Khoramjouy, M; Malekinejad, H; Mehrabi, M; Rezaei-Golmisheh, A | 1 |
Dang, XM; Ma, AQ; Yang, L; Zhu, B | 1 |
Cui, W; Du, H; Hao, J; Liu, D; Liu, F; Lu, J; Yang, X | 1 |
Marques, PP; Oliveira, LP; Pimentel, ER; Vieira, CP | 1 |
Huang, HS; Liu, CJ; Tsai, YS | 1 |
10 other study(ies) available for hydroxyproline and atorvastatin
Article | Year |
---|---|
[Effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats].
Topics: Animals; Anticholesteremic Agents; Apoptosis; Atorvastatin; Blood Pressure; Heptanoic Acids; Hydroxyproline; Hypertension; Lipids; Male; Myocardium; Proliferating Cell Nuclear Antigen; Pyrroles; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Up-Regulation; Ventricular Remodeling | 2007 |
Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions.
Topics: Administration, Oral; Alanine; Animals; Atorvastatin; Carbon Tetrachloride; Collagen; Deuterium Oxide; Drug Evaluation, Preclinical; Enalapril; Gas Chromatography-Mass Spectrometry; Griseofulvin; Heptanoic Acids; Hydroxyproline; Interferon-gamma; Liver; Liver Cirrhosis, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pyrroles; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Rosiglitazone; Species Specificity; Thiazolidinediones; Time Factors | 2007 |
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.
Topics: Animals; Atorvastatin; Blood Pressure; Enzyme Activation; Heptanoic Acids; Hydroxyproline; Intracellular Signaling Peptides and Proteins; Liver Cirrhosis; Male; Nitric Oxide Synthase Type III; Portal System; Protein Serine-Threonine Kinases; Pyrroles; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; rhoA GTP-Binding Protein | 2007 |
Atorvastatin reverses cardiac remodeling possibly through regulation of protein kinase D/myocyte enhancer factor 2D activation in spontaneously hypertensive rats.
Topics: Animals; Atorvastatin; Blood Pressure; Disease Models, Animal; Enzyme Activation; Fibrosis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Hypertension; Hypertrophy, Left Ventricular; Lipids; Male; MEF2 Transcription Factors; Myocardium; Protein Kinase C; Pyrroles; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Time Factors; Transcription Factors; Ventricular Remodeling | 2010 |
Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.
Topics: Animals; Apoptosis; Atorvastatin; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Muscle Contraction; Myocardial Infarction; Myocytes, Cardiac; Pyrroles; Rats; Rats, Inbred F344; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: role of PPARĪ³ receptors.
Topics: Anilides; Animals; Atorvastatin; Body Weight; Heptanoic Acids; Herbicides; Hydroxyproline; Lung; Male; Organ Size; Paraquat; Pioglitazone; PPAR gamma; Protective Agents; Pulmonary Fibrosis; Pyrroles; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Transforming Growth Factor beta1 | 2013 |
Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)/ERK signaling pathway.
Topics: Animals; Atorvastatin; Bleomycin; Body Weight; Collagen; Connective Tissue Growth Factor; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Pulmonary Fibrosis; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction | 2013 |
Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats.
Topics: Administration, Oral; Amlodipine; Animals; Antihypertensive Agents; Atorvastatin; Cardiomegaly; Cross-Sectional Studies; Disease Models, Animal; Gene Expression Profiling; Hydroxyproline; Hypertension; Immunohistochemistry; Male; Myocardium; NF-kappa B; Osteoprotegerin; RANK Ligand; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Ventricular Function, Left | 2016 |
Do different tendons exhibit the same response following chronic exposure to statins?
Topics: Animals; Atorvastatin; Collagen Type I; Enzyme Precursors; Extracellular Matrix; Gelatinases; Glycosaminoglycans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Hyperlipidemias; Male; Rats; Rats, Wistar; Simvastatin; Tendon Injuries; Tendons | 2017 |
Atorvastatin Decreases Renal Calcium Oxalate Stone Deposits by Enhancing Renal Osteopontin Expression in Hyperoxaluric Stone-Forming Rats Fed a High-Fat Diet.
Topics: Animals; Atorvastatin; Calcium; Calcium Oxalate; Diet, High-Fat; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxyproline; Hyperoxaluria; Kidney Calculi; Nephrolithiasis; Osteopontin; Rats; Rats, Sprague-Dawley | 2022 |